Pfam Domains GO Terms
| Aldolase II |
| positive regulation of endothelial cell development |
| positive regulation of establishment of endothelial barrier |
| F-actin capping protein complex |
| hemoglobin metabolic process |
| regulation of endothelial cell development |
| regulation of establishment of endothelial barrier |
| barbed-end actin filament capping |
| positive regulation of endothelial cell differentiation |
| cell volume homeostasis |
| spectrin binding |
| homeostasis of number of cells within a tissue |
| plasma membrane raft |
| positive regulation of adherens junction organization |
| actin filament capping |
| regulation of endothelial cell differentiation |
| negative regulation of actin filament depolymerization |
| regulation of actin filament depolymerization |
| negative regulation of actin filament polymerization |
| IRE1-mediated unfolded protein response |
| positive regulation of epithelial cell differentiation |
| negative regulation of protein depolymerization |
| actin filament bundle assembly |
| actin filament bundle organization |
| negative regulation of protein polymerization |
| regulation of adherens junction organization |
| negative regulation of protein complex disassembly |
| erythrocyte differentiation |
| multicellular organism growth |
| cellular response to calcium ion |
| regulation of protein depolymerization |
| erythrocyte homeostasis |
| positive regulation of protein binding |
| structural constituent of cytoskeleton |
| endoplasmic reticulum unfolded protein response |
| cell-cell adherens junction |
| myeloid cell homeostasis |
| regulation of protein complex disassembly |
| cellular response to unfolded protein |
| negative regulation of protein complex assembly |
| negative regulation of supramolecular fiber organization |
| negative regulation of cytoskeleton organization |
| regulation of epithelial cell differentiation |
| cellular response to topologically incorrect protein |
| response to calcium ion |
| response to unfolded protein |
| regulation of actin filament polymerization |
| positive regulation of binding |
| regulation of cell size |
| regulation of actin polymerization or depolymerization |
| regulation of actin filament length |
| response to topologically incorrect protein |
| tissue homeostasis |
| cellular response to metal ion |
| structural molecule activity |
| homeostasis of number of cells |
| calmodulin binding |
| actin filament binding |
| regulation of protein binding |
| cellular response to inorganic substance |
| myeloid cell differentiation |
| regulation of protein polymerization |
| actin filament organization |
| postsynaptic density |
| response to endoplasmic reticulum stress |
| regulation of actin filament organization |
| actin binding |
| nuclear body |
| cadherin binding |
| multicellular organismal homeostasis |
| transcription factor binding |
| anatomical structure homeostasis |
| regulation of actin cytoskeleton organization |
| regulation of supramolecular fiber organization |
| cytoskeleton |
| response to metal ion |
| negative regulation of organelle organization |
| regulation of binding |
| in utero embryonic development |
| regulation of cellular component size |
| developmental growth |
| regulation of actin filament-based process |
| growth |
| focal adhesion |
| regulation of protein complex assembly |
| supramolecular fiber organization |
| protein heterodimerization activity |
| actin cytoskeleton organization |
| regulation of anatomical structure size |
| response to inorganic substance |
| regulation of cytoskeleton organization |
| positive regulation of cell development |
| hemopoiesis |
| actin filament-based process |
| hematopoietic or lymphoid organ development |
| chordate embryonic development |
| immune system development |
| embryo development ending in birth or egg hatching |
| negative regulation of cellular component organization |
| cell morphogenesis |
| cellular component morphogenesis |
| protein homodimerization activity |
| cellular homeostasis |
| regulation of cell development |
| regulation of cellular component biogenesis |
| positive regulation of cell differentiation |
| embryo development |
| cytoskeleton organization |
| positive regulation of cellular component organization |
| transmembrane transport |
| regulation of organelle organization |
| positive regulation of developmental process |
| RNA binding |
| homeostatic process |
| cellular response to stress |
| positive regulation of molecular function |
| regulation of cell differentiation |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Screen | Score |
|---|---|
| Myriocin 25μM R06 exp293 | -1.91 |
| R-DABN 8μM R03 exp111 | -1.77 |
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Expression Distribution